{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:14:35Z","timestamp":1793830475224,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Faculty of Medicine, Khon Kaen University"},{"name":"the Research and Graduate Studies, Khon Kaen University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Systemic sclerosis (SSc) is recognized as a chronic inflammatory disease and several SSc-associated factors may increase the risk of osteoporosis and its related fractures. To determine the prevalence and predictive factors of osteoporosis in Thai SSc, a cross-sectional study was designed in adult SSc patients at Scleroderma clinic, Khon Kaen University Hospital. The prevalence of osteoporosis with the 95% confidence interval (CI) were determined and the odds ratio (OR) with 95%CI were assessed the clinical association with osteoporosis. A total of 205 SSc patients were recruited with the female to male ratio of 2.7:1. The majority of cases were diffuse SSc subset (83.4%) with a disease duration\u2009&lt;\u20095\u00a0years (62.9%). The overall prevalence of osteoporosis was 29.3% (95%CI 23.1\u201336.0). After an age adjusted analysis, the respective prevalence of osteoporosis at lumbar spine (LS) in women and men was 26.3% and 10%, while the prevalence of osteoporosis at the femoral neck (FN) in women and men was 11% and 2.1%. Low BMI (\u2264\u200918.5\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) and menopause were associated with osteoporosis at both the LS and FN. Using multivariate analysis, low BMI and menopause were associated with osteoporosis at LS (OR 7.78 and 5.32, respectively),\u00a0while low BMI was also associated with osteoporosis at LS in pre-menopausal women. In conclusion, the prevalence of osteoporosis in Thai SSc was 29.3%. Osteoporosis at the LS is more common than FN in both men and women. Low BMI was associated with osteoporosis in overall SSc and pre-menopausal women, while only menopause was associated with osteoporosis at the FN.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88792-6","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:03:25Z","timestamp":1620021805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Wiriya","family":"Chuealee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatlert","family":"Pongchaiyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratanavadee","family":"Nanagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"88792_CR1","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285, 785\u2013795 (2001).","DOI":"10.1001\/jama.285.6.785"},{"key":"88792_CR2","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1016\/S0002-9343(97)90022-X","volume":"103","author":"C Cooper","year":"1997","unstructured":"Cooper, C. The crippling consequences of fractures and their impact on quality of life. Am. J. Med. 103, 12S-17S (1997) (discussion 17S\u201319S).","journal-title":"Am. J. Med."},{"key":"88792_CR3","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman, F. et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos. Int. 25, 2359\u20132381 (2014).","journal-title":"Osteoporos. Int."},{"key":"88792_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"C Cooper","year":"1992","unstructured":"Cooper, C., Campion, G. & Melton, L. J. Hip fractures in the elderly: a world-wide projection. Osteoporos. Int. 2, 285\u2013289 (1992).","journal-title":"Osteoporos. Int."},{"key":"88792_CR5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli, A., Avvedimento, E. V. & Krieg, T. Scleroderma. N. Engl. J. Med. 360, 1989\u20132003 (2009).","journal-title":"N. Engl. J. Med."},{"key":"88792_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga, J., Trojanowska, M. & Kuwana, M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J. Scleroderma Relat. Disord. 2, 137\u2013152 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"88792_CR7","doi-asserted-by":"publisher","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","volume":"4","author":"V Smith","year":"2018","unstructured":"Smith, V. et al. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 4, e000782 (2018).","journal-title":"RMD Open"},{"key":"88792_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","volume":"41","author":"P Hissaria","year":"2011","unstructured":"Hissaria, P. et al. Survival in scleroderma: results from the population-based South Australian Register. Intern. Med. J. 41, 381\u2013390 (2011).","journal-title":"Intern. Med. J."},{"key":"88792_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/keg033","volume":"42","author":"CP Sime\u00f3n","year":"2003","unstructured":"Sime\u00f3n, C. P. et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 42, 71\u201375 (2003).","journal-title":"Rheumatology (Oxford)"},{"key":"88792_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher, F. F., Pope, J. E. & Ouimet, J. M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 39, 269\u2013277 (2010).","journal-title":"Semin. Arthritis Rheum."},{"key":"88792_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.semarthrit.2004.08.006","volume":"34","author":"J Loucks","year":"2005","unstructured":"Loucks, J. & Pope, J. E. Osteoporosis in scleroderma. Semin. Arthritis Rheum. 34, 678\u2013682 (2005).","journal-title":"Semin. Arthritis Rheum."},{"key":"88792_CR12","first-page":"1073","volume":"35","author":"SY Yuen","year":"2008","unstructured":"Yuen, S. Y., Rochwerg, B., Ouimet, J. & Pope, J. E. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J. Rheumatol. 35, 1073\u20131078 (2008).","journal-title":"J. Rheumatol."},{"key":"88792_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/BF02208027","volume":"10","author":"G La Montagna","year":"1991","unstructured":"La Montagna, G., Vatti, M., Valentini, G. & Tirri, G. Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin. Rheumatol. 10, 18\u201322 (1991).","journal-title":"Clin. Rheumatol."},{"key":"88792_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/ard.2003.011064","volume":"63","author":"B Frediani","year":"2004","unstructured":"Frediani, B. et al. Bone mineral density in patients with systemic sclerosis. Ann. Rheum. Dis. 63, 326\u2013327 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"88792_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/03009740600704296","volume":"35","author":"RBC Souza","year":"2006","unstructured":"Souza, R. B. C., Borges, C. T. L., Takayama, L., Aldrighi, J. M. & Pereira, R. M. R. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand. J. Rheumatol. 35, 384\u2013387 (2006).","journal-title":"Scand. J. Rheumatol."},{"key":"88792_CR16","first-page":"180","volume":"23","author":"PD Sampaio-Barros","year":"2005","unstructured":"Sampaio-Barros, P. D. et al. Prognostic factors of low bone mineral density in systemic sclerosis. Clin. Exp. Rheumatol. 23, 180\u2013184 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"key":"88792_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/38.4.371","volume":"38","author":"L Carbone","year":"1999","unstructured":"Carbone, L., Tylavsky, F., Wan, J., McKown, K. & Cheng, S. Bone mineral density in scleroderma. Rheumatology (Oxford) 38, 371\u2013372 (1999).","journal-title":"Rheumatology (Oxford)"},{"key":"88792_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/rheumatology\/kes240","volume":"52","author":"CC Mok","year":"2013","unstructured":"Mok, C. C., Chan, P. T., Chan, K. L. & Ma, K. M. Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: a case-control study. Rheumatology (Oxford) 52, 296\u2013303 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"88792_CR19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/acr.21761","volume":"64","author":"J Avouac","year":"2012","unstructured":"Avouac, J. et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res. (Hoboken) 64, 1871\u20131878 (2012).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"88792_CR20","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23, 581\u2013590 (1980).","DOI":"10.1002\/art.1780230510"},{"key":"88792_CR21","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202\u2013205 (1988).","journal-title":"J. Rheumatol."},{"key":"88792_CR22","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00296-011-2150-1","volume":"32","author":"Y Ibn Yacoub","year":"2012","unstructured":"Ibn Yacoub, Y. et al. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol. Int. 32, 3143\u20133148 (2012).","journal-title":"Rheumatol. Int."},{"key":"88792_CR23","doi-asserted-by":"crossref","unstructured":"Maeda, K., Ishida, Y., Nonogaki, T. & Mori, N. Reference body mass index values and the prevalence of malnutrition according to the Global Leadership Initiative on Malnutrition criteria. Clinical nutrition (Edinburgh, Scotland). Clin Nutr. 39, 180\u2013184 (2020)","DOI":"10.1016\/j.clnu.2019.01.011"},{"key":"88792_CR24","doi-asserted-by":"crossref","unstructured":"Baron, M., Hudson, M., Steele, R. & Canadian Scleroderma Research Group. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J. Rheumatol. 36, 2737\u20132743 (2009).","DOI":"10.3899\/jrheum.090694"},{"key":"88792_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10067-013-2235-1","volume":"32","author":"TF Marighela","year":"2013","unstructured":"Marighela, T. F., Genaro, P. D. S., Pinheiro, M. M., Szejnfeld, V. L. & Kayser, C. Risk factors for body composition abnormalities in systemic sclerosis. Clin. Rheumatol. 32, 1037\u20131044 (2013).","journal-title":"Clin. Rheumatol."},{"key":"88792_CR26","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1152\/ajpendo.00293.2017","volume":"314","author":"GB Marchand","year":"2018","unstructured":"Marchand, G. B. et al. Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women. Am. J. Physiol. Endocrinol. Metab. 314, E448\u2013E456 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"88792_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jbspin.2011.06.002","volume":"79","author":"J Paccou","year":"2012","unstructured":"Paccou, J., Dewailly, J. & Cortet, B. Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine 79, 78\u201382 (2012).","journal-title":"Joint Bone Spine"},{"key":"88792_CR28","doi-asserted-by":"publisher","first-page":"14865","DOI":"10.18632\/oncotarget.3806","volume":"6","author":"M Marot","year":"2015","unstructured":"Marot, M. et al. Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study. Oncotarget 6, 14865\u201314873 (2015).","journal-title":"Oncotarget"},{"key":"88792_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4137\/CMAMD.S7773","volume":"4","author":"EA Hafez","year":"2011","unstructured":"Hafez, E. A. et al. Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin. Med. Insights Arthritis Musculoskelet. Disord. 4, 87\u201394 (2011).","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"88792_CR30","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/rheumatology\/key130","volume":"57","author":"B Ruaro","year":"2018","unstructured":"Ruaro, B. et al. Correlation between bone quality and microvascular damage in systemic sclerosis patients. Rheumatology (Oxford) 57, 1548\u20131554 (2018).","journal-title":"Rheumatology (Oxford)"},{"key":"88792_CR31","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10067-018-4322-9","volume":"37","author":"B Ruaro","year":"2018","unstructured":"Ruaro, B. et al. Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). Clin. Rheumatol. 37, 3057\u20133062 (2018).","journal-title":"Clin. Rheumatol."},{"key":"88792_CR32","first-page":"1822","volume":"27","author":"K Neumann","year":"2000","unstructured":"Neumann, K., Wallace, D. J. & Metzger, A. L. Osteoporosis\u2013less than expected in patients with scleroderma?. J. Rheumatol. 27, 1822\u20131823 (2000).","journal-title":"J. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88792-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88792-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88792-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:38:20Z","timestamp":1670035100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88792-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88792"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88792-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9424"}}